Toronto's interest in Max Scherzer emphasizes their ongoing strategy to enhance the pitching rotation while capitalizing on Scherzer's recent buy-low potential.
Despite a challenging 2024 season marred by injuries, Scherzer's ability to maintain a 3.95 ERA is noteworthy, highlighting his talent even in a limited capacity.
Scherzer's past durability raises questions about whether the accumulated strain from 2878 innings has finally affected his performance as he ages beyond 40.
After undergoing back surgery, Scherzer's recent mechanical adjustments appear to have resolved some of his nerve issues, signaling a potential return to form.
Collection
[
|
...
]